Rotavirus virus-like particles administered mucosally induce protective immunity

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8707-8717

  O'Neal, Christine M ^a   Crawford, Sue E ^a   Estes, Mary K ^a   Conner, Margaret E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; ROTAVIRUS VACCINE; STRUCTURAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ROTAVIRUS; VIRUS INFECTION; VIRUS PARTICLE; VIRUS SHEDDING;

EID: 0030821175     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8707-8717.1997     Document Type: Article

References (72)

1. Andrew, M. E., D. B. Boyle, B. E. H. Coupar, D. Reddy, A. R. Bellamy, and G. W. Both. 1992. Vaccinia-rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea. Vaccine 10:185-191.
2. Ball, J. M., M. E. Hardy, R. L. Atmar, M. E. Conner, and M. K. Estes. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. Submitted for publication.
3. Bergmann, K.-C., and R. H. Waldman. 1988. Stimulation of secretory antibody following oral administration of antigen. Rev. Infect. Dis. 10:939-944.
4. Bergquist, C., T. Lagergard, M. Lindblad, and J. Holmgren. 1995. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect. Immun. 63:2021-2025.
5. Both, G. W., L. J. Lockett, V. Janardhana, S. J. Edwards, A. R. Bellamy, F. L. Graham, L. Prevec, and M. E. Andrew. 1993. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology 193:940-950.
6. Bridger, J. C., and G. Oldham. 1987. Avirulent rotavirus infections protect calves from disease with and without inducing high levels of neutralizing antibody. J. Gen. Virol. 68:2311-2317.
7. Brown, K. A., C. A. Moser, T. J. Speaker, C. A. Khoury, J. E. Kim, and P. A. Offit. 1995. Enhancement by microencapsulation of rotavirus-specific intestinal immune responses in mice assessed by enzyme-linked immunospot assay and intestinal fragment culture. J. Infect. Dis. 171:1334-1338.
8. Burns, J. W., H. B. Greenberg, R. D. Shaw, and M. K. Estes. 1988. Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J. Virol. 62:2164-2172.
9. Burns, J. W., M. Siadat-Pajouh, A. A. Krishnaney, and H. B. Greenberg. 1996. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 272:104-106.
10. Challacombe, S. J. 1987. Cellular factor in the induction of mucosal immunity by oral immunization. Adv. Exp. Med. Biol. 216:887-899.
11. Chiba, S., T. Yokoyama, S. Nakata, Y. Morita, T. Urasawa, K. Taniguchi, S. Urasawa, and T. Nakao. 1986. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 2:417-421.
12. Ciarlet, M., S. E. Crawford, C. Barone, A. Bertolotti-Ciarlet, M. K. Estes, and M. E. Conner. Unpublished data.
13. Ciarlet, M., M. Hidalgo, M. Gorziglia, and F. Liprandi. 1994. Characterization of neutralization epitopes on the VP7 surface protein of serotype G11 porcine rotaviruses. J. Gen. Virol. 75:1867-1873.
14. Clark, H. F., F. E. Borian, L. M. Bell, K. Modesto, V. Gouvea, and S. A. Plotkin. 1988. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J. Infect. Dis. 158:570-587.
15. Coffin, S. E., M. Klinek, and P. A. Offit. 1995. Induction of virus-specific antibody production by lamina propria lymphocytes following intramuscular inoculation with rotavirus. J. Infect. Dis. 172:874-878.
16. Conner, M. E., S. E. Crawford, C. Barone, and M. K. Estes. 1993. Rotavirus vaccine administered parenterally induces protective immunity. J. Virol. 67:6633-6641.
17. Conner, M. E., M. K. Estes, and D. Y. Graham. 1988. Rabbit model of rotavirus infection. J. Virol. 62:1625-1633.
18. Conner, M. E., M. K. Estes, P. A. Offit, H. F. Clark, M. Franco, N. Feng, and H. B. Greenberg. 1996. Development of a mucosal rotavirus vaccine, p. 325H. In P. Kiyono, L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, San Diego, Calif.
19. Conner, M. E., M. A. Gilger, M. K. Estes, and D. Y. Graham. 1991. Serologic and mucosal immune response to rotavirus infection in the rabbit model. J. Virol. 65:2562-2571.
20. Conner, M. E., C. D. Zarley, B. Hu, S. Parsons, D. Drabinski, S. Greiner, R. Smith, B. Jiang, B. Corsaro, V. Barniak, H. P. Madore, S. E. Crawford, and M. K. Estes. 1996. Virus-like particles as a rotavirus subunit vaccine. J. Infect. Dis. 174:S88-S92.
21. Crawford, S. E., M. Ciarlet, M. K. Estes, C. Barone, C. M. O'Neal, J. Cohen, and M. E. Conner. Induction of heterotypic neutralizing antibodies by rotavirus-like particles. Unpublished data.
22. Crawford, S. E., M. Labbe, J. Cohen, M. H. Burroughs, Y. Zhou, and M. K. Estes. 1994. Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J. Virol. 68:5945-5952.
23. + T lymphocytes. J. Virol. 64:4375-4382.
24. Dickinson, B. L., and J. D. Clements. 1996. Use of Escherichia coli heat-liable enterotoxin as an oral adjuvant, p. 73-87. In H. Kiyono, P. L. Ogra, and J. R. McGhee (eds.), Mucosal vaccines. Academic Press, Inc., San Diego Calif.
25. Elson, C. O. 1996. Cholera toxin as a mucosal adjuvant, p. 59-72. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, Inc., San Diego, Calif.
26. Ericson, B. L., D. Y. Graham, B. B. Mason, and M. K. Estes. 1982. Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J. Virol. 42:825-839.
27. Feng, N., J. W. Burns, L. Bracy, and H. B. Greenberg. 1994. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J. Virol. 68:7766-7773.
28. Fiore, L., S. J. Dunn, B. Ridolfi, F. M. Ruggeri, E. R. Mackow, and H. B. Greenberg. 1995. Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus. J. Gen. Virol. 76:1981-1988.
29. Flores, J., G. Daoud, N. Daoud, M. Puig, M. Martinez, I. Perez-Schael, R. Shaw, H. B. Greenberg, K. Midthun, and A. Z. Kapikian. 1988. Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela. Pediatr. Infect. Dis. J. 7:776-780.
30. Franco, M. A., and H. B. Greenberg. 1995. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol. 69:7800-7806.
31. + T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice. J. Virol. 71:4165-4170.
32. Gizurarson, S., V. M. Jonsdottir, and I. Heron. 1995. Intranasal administration of diphtheria toxoid. Selecting antibody isotypes using formulations having various lipophilic characteristics. Vaccine 13:617-621.
33. Haneberg, B., D. Kendall, H. M. Amerongen, F. M. Apter, J.-P. Kraehenbuhl, and M. Neutra. 1994. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 62:15-23.
34. Heinz, F. X., M. Roggendorf, H. Hofmann, C. Kunz, and F. Deinhardt. 1981. Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tick-borne encephalitis virus in serum and cerebrospinal fluid. J. Clin. Microbiol. 14:141-146.
35. Herbrink, P., A. M. Van Loon, J. P. Rotmans, F. Van Knapen, and W. C. Van Dijk. 1987. Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii. J. Clin. Microbiol. 26:100-105.
36. Hirabayashi, Y., H. Kurata, H. Funato, T. Nagamine, C. Aizawa, S.-I. Tamura, K. Shimada, and T. Kurata. 1990. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 8:243-248.
37. Hoshino, Y., L. J. Saif, M. M. Sereno, R. M. Chanock, and A. Z. Kapikian. 1988. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen. J. Virol. 62:744-748.
38. Institute of Medicine. 1986. New vaccine development. Establishing priorities. Diseases of importance in developing countries, vol. II, p. 308-318. National Academy Press, Washington, D.C.
39. Khoury, C. A., C. A. Moser, T. J. Speaker, and P. A. Offit. 1995. Oral inoculation of mice with low doses of microencapsulated, noninfectious rotavirus induces virus-specific antibodies in gut-associated lymphoid tissue. J. Infect. Dis. 172:870-874.
40. LeBaron, C. W., J. Lew, R. I. Glass, J. M. Weber, G. M. Ruiz-Palacios, and Rotavirus Study Group. 1990. Annual rotavirus epidemic patterns in North America. Results of a 5-year retrospective survey of 88 centers in Canada, Mexico, and the United States. JAMA 264:983-988.
41. Lee, K. K., M. Ciarlet, and M. E. Conner. 1997. Unpublished data.
42. Lycke, N., and J. Holmgren. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59:301-308.
43. Mackow, E. R., P. T. Vo, R. Broome, D. Bass, and H. B. Greenberg. 1990. Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J. Virol. 64:1698-1703.
44. Matsui, S. M., P. A. Offit, P. T. Vo, E. R. Mackow, D. A. Benfield, R. D. Shaw, L. Padilla-Noriega, and H. B. Greenberg. 1989. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J. Clin. Microbiol 27:780-782.
45. Mattingly, J. A., and B. H. Waksman. 1980. Immunologie suppression after oral administration of antigen. II. Antigen specific helper and suppressor factors produced by spleen cells of rats fed sheep erythrocytes. J. Immunol. 125:1044-1047.
46. McDermott, M. R., and J. Bienenstock. 1979. Evidence for a common mucosal immunologic system. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 122:1892-1898.
47. McNeal, M. M., K. S. Barone, M. N. Rae, and R. L. Ward. 1995. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology 214:387-397.
48. Murphy, B. R. 1994. Mucosal immunity to viruses, p. 333-343. In P. L. Ogra, W. Strober, J. Mestecky, J. R. McGhee, M. E. Lamm, and J. Bienenstock (ed.), Handbook of mucosal immunology. Academic Press, Inc., San Diego, Calif.
49. Offit, P. A., and H. F. Clark. 1985. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J. Virol. 54:58-64.
50. Offit, P. A., and K. I. Dudzik. 1989. Noninfectious rotavirus (strain RRV) induces an immune response in mice which protects against rotavirus challenge. J. Clin. Microbiol. 27:885-888.
51. Offit, P. A., and K. I. Dudzik. 1990. Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J. Virol. 64:6325-6328.
52. Offit, P. A., C. A. Khoury, C. A. Moser, H. F. Clark, J. E. Kim, and T. J. Speaker. 1994. Enhancement of rotavirus immunogenicity by microencapsulation. Virology 203:134-143.
53. Offit, P. A., R. D. Shaw, and H. B. Greenberg. 1986. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J. Virol. 58:700-703.
54. O'Neal, C. M., J. D. Clements, M. K. Estes, and M. E. Conner. Rotavirus 2/6-VLPs administered intranasally with cholera toxin, E. coli heat labile toxin and LT-R192G induce protection from rotavirus challenge. Submitted for publication.
55. O'Ryan, M. L., D. O. Matson, M. K. Estes, and L. K. Pickering. 1994. Anti-rotavirus G type-specific and isotype-spectfic antibodies in children with natural rotavirus infections. J. Infect. Dis. 169:504-511.
56. Perez-Schael, I., D. Garcia, M. Gonzalez, R. Gonzalez, N. Daoud, M. Perez, W. Cunto, A. Z. Kapikian, and J. Flores. 1990. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J. Med. Virol. 30:219-229.
57. Quiding-Jarbrink, M., G. Granstrom, I. Nordstrom, J. Holmgren, and C. Czerkinsky. 1995. Induction of compartmentalized B-cell responses in human tonsils. Infect. Immun. 63:853-857.
58. Rudzik, R., R. L. Clancy, D. Y. E. Perey, R. P. Day, and J. Bienenstock. 1975. Repopulation with IgA-containing cells of bronchial and intestinal lamina propria after transfer of homologous peyer's patch and bronchial lymphocytes. J. Immunol. 114:1599-1604.
59. Sheridan, J. F., C. C. Smith, M. M. Manak, and L. Aurelian. 1984. Prevention of rotavirus-induced diarrhea in neonatal mice born to dams immunized with empty capsids of simian rotavirus SA-11. J. Infect. Dis. 149:434-438.
60. Smith, J. C., A. C. Haddix, S. M. Teutsch, and R. I. Glass. 1995. Cost-effectiveness analysis of a rotavirus immunization program for the United States. Pediatrics 96:609-615.
61. Sosroseno, W. 1995. A review of the mechanisms of oral tolerance and immunotherapy. J. R. Soc. Med. 88:14-17.
62. 1. J. Immunol. 157:462-472.
63. Tamura, S.-I, Y. Samegai, H. Kurata, K. Kikuta, T. Nagamine, C. Aizawa, and T. Kurata. 1989. Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine. Vaccine 7:257-262.
64. Tamura, S.-I., Y. Samegai, H. Kurata, T. Nagamine, C. Aizawa, and T. Kurata. 1988. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 6:409-413.
65. VanCott, J. L., T. A. Brim, J. K. Lunney, and L. J. Saif. 1994. Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J. Immun. 152:3980-3990.
66. Ward, R. L., D. I. Bernstein, R. Shukla, E. C. Young, J. R. Sherwood, M. M. McNeal, M. C. Walker, and G. M. Schiff. 1989. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J. Infect. Dis. 159:79-88.
67. Ward, R. L., M. M. McNeal, and J. F. Sheridan. 1990. Development of an adult mouse model for studies on protection against rotavirus. J. Virol. 64:5070-5075.
68. Ward, R. L., M. M. McNeal, and J. F. Sheridan. 1992. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. Virology 188:57-66.
69. Weisz-Carrington, P., M. E. Roux, M. McWilliams, J. M. Phillips-Quagliata, and M. E. Lamm. 1979. Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system. J. Immunol. 123:1705-1708.
70. Woode, G. N., S. L. Zheng, B. I. Rosen, N. Knight, N. E. Gourley, and R. F. Ramig. 1987. Protection between different serotypes of bovine rotavirus in gnotobiotic calves: specificity of serum antibody and coproantibody responses. J. Clin. Microbiol. 25:1052-1058.
71. Wu, H.-Y., and M. W. Russell. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61:314-322.
72. Yuan, L., L. A. Ward, B. I. Rosen, T. L. To, and L. J. Saif. 1996. Systemic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Virol. 70:3075-3083.